Katherine Montag Schafer, PharmD, BCACP, CDCES

Primary Care Pharmacist, CDCES, Assistant Professor @UMNFamilyMed, Adjunct Professor @UMN_Pharmacy. Opinions do not represent the views of my institution.

[Katherine Montag Schafer, PharmD, BCACP, CDCES @KMS_PharmD]

Thanks @iforumrx for having Dr Kyle Hunt and I to talk about Finerenone, another tool for treating CKD in diabetes! https://t.co/rdK96xdqPC

[Katherine Montag Schafer, PharmD, BCACP, CDCES @KMS_PharmD]

We have lots of experience with bisphosphonates, but what do we do for those who have comorbid conditions that prevent their use? Denosumab is an alternative first line choice! (3/n)

[Katherine Montag Schafer, PharmD, BCACP, CDCES @KMS_PharmD]

Brought to you in partnership with @BrowntownMD.
Our summary of the literature for screening and treatment recommendations for osteoporosis, with a primary care lens. ⬇️ (1/n)

[Katherine Montag Schafer, PharmD, BCACP, CDCES @KMS_PharmD]

In addition to determining who qualifies for treatment, the FRAX tool (https://t.co/DWPFTpiZ0I) should be used in younger women deemed at risk for osteoporosis to determine if DXA screening recommended. (2/n)